BioCorRx (BICX) Current Deferred Revenue (2010 - 2026)
BioCorRx (BICX) posted Current Deferred Revenue of $56590.0 for Q3 2025, little changed sequentially from $56590.0 in Q2 2025.
BioCorRx (BICX) Current Deferred Revenue (2010 - 2026) Analysis & Trends
BioCorRx has reported Current Deferred Revenue for 16 years, with the latest figure at $56590.0 in Q3 2025.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $56590.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $56590.0 (changed N/A YoY) and the FY2024 annual result came in at $56590.0, up 1299.01% from the prior year.
- Current Deferred Revenue was little changed at $56590.0 in Q3 2025 per BICX's latest filing, from $56590.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $81099.0 in Q3 2021 and troughed at $4045.0 in Q1 2023.
- A 5-year average of $36161.4 and a median of $34981.0 in 2021 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue sank 91.23% in 2023, then soared 1299.01% in 2024.
- Over 5 years, Current Deferred Revenue stood at $72282.0 in 2021, then sank by 48.4% to $37301.0 in 2022, then plunged by 89.16% to $4045.0 in 2023, then jumped by 1299.01% to $56590.0 in 2024, then changed by 0.0% to $56590.0 in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $56590.0, $56590.0, and $56590.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,040.00 |
| Sep 30, 2025 | 56,590.00 |
| Jun 30, 2025 | 56,590.00 |
| Dec 31, 2024 | 56,590.00 |
| Mar 31, 2024 | 4,045.00 |
| Dec 31, 2023 | 4,045.00 |
| Sep 30, 2023 | 4,045.00 |
| Jun 30, 2023 | 15,909.00 |
| Mar 31, 2023 | 4,045.00 |
| Dec 31, 2022 | 37,301.00 |
| Sep 30, 2022 | 46,118.00 |
| Jun 30, 2022 | 34,981.00 |
| Mar 31, 2022 | 34,981.00 |
| Dec 31, 2021 | 72,282.00 |
| Sep 30, 2021 | 81,099.00 |
| Jun 30, 2021 | 34,981.00 |
| Mar 31, 2021 | 34,981.00 |
| Dec 31, 2020 | 135,612.00 |
| Sep 30, 2020 | 74,935.00 |
| Jun 30, 2020 | 95,077.00 |